LeConte Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
760
+52
+7% +$18.5K 0.17% 105
2025
Q4
$232K Sell
708
-28
-4% -$8.88K 0.15% 114
2025
Q3
$208K Sell
736
-40
-5% -$11.6K 0.14% 119
2025
Q2
$217K Buy
+776
New +$220K 0.15% 91

Other funds holding AMGN

LeConte Wealth Management's AMGN Position: Q1 2026 in Review

LeConte Wealth Management increased its Amgen (AMGN) stake by 7.3% in Q1 2026, buying an estimated $18.5K and bringing the position to 760 shares worth $267K. The position accounts for 0.17% of the portfolio, ranked #105.

LeConte Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • LeConte Wealth Management held 760 shares of Amgen worth $267K as of Q1 2026.
  • LeConte Wealth Management bought 52 Amgen shares in Q1 2026, an estimated $18.5K.
  • Amgen made up 0.17% of LeConte Wealth Management's portfolio in Q1 2026, its #105 holding.
  • LeConte Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.